BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1447 related articles for article (PubMed ID: 11034764)

  • 21. Antidepressants for people with epilepsy and depression.
    Maguire MJ; Weston J; Singh J; Marson AG
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010682. PubMed ID: 25464360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mirtazapine versus other antidepressive agents for depression.
    Watanabe N; Omori IM; Nakagawa A; Cipriani A; Barbui C; Churchill R; Furukawa TA
    Cochrane Database Syst Rev; 2011 Dec; (12):CD006528. PubMed ID: 22161405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Newer generation antidepressants for depressive disorders in children and adolescents.
    Hetrick SE; McKenzie JE; Cox GR; Simmons MB; Merry SN
    Cochrane Database Syst Rev; 2012 Nov; 11(11):CD004851. PubMed ID: 23152227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease.
    Pollok J; van Agteren JE; Carson-Chahhoud KV
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012346. PubMed ID: 30566235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Citalopram versus other anti-depressive agents for depression.
    Cipriani A; Purgato M; Furukawa TA; Trespidi C; Imperadore G; Signoretti A; Churchill R; Watanabe N; Barbui C
    Cochrane Database Syst Rev; 2012 Jul; 7(7):CD006534. PubMed ID: 22786497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.
    Song F; Freemantle N; Sheldon TA; House A; Watson P; Long A; Mason J
    BMJ; 1993 Mar; 306(6879):683-7. PubMed ID: 8471919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antidepressants for insomnia in adults.
    Everitt H; Baldwin DS; Stuart B; Lipinska G; Mayers A; Malizia AL; Manson CC; Wilson S
    Cochrane Database Syst Rev; 2018 May; 5(5):CD010753. PubMed ID: 29761479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discontinuation rates of SSRIs and tricyclic antidepressants: a meta-analysis and investigation of heterogeneity.
    Hotopf M; Hardy R; Lewis G
    Br J Psychiatry; 1997 Feb; 170():120-7. PubMed ID: 9093499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drop-out rates in placebo-controlled trials of antidepressant drugs: A systematic review and meta-analysis based on clinical study reports.
    Sharma T; Guski LS; Freund N; Meng DM; Gøtzsche PC
    Int J Risk Saf Med; 2019; 30(4):217-232. PubMed ID: 31561390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amitriptyline v. the rest: still the leading antidepressant after 40 years of randomised controlled trials.
    Barbui C; Hotopf M
    Br J Psychiatry; 2001 Feb; 178():129-44. PubMed ID: 11157426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. WITHDRAWN: Selective serotonin reuptake inhibitors (SSRIs) versus other antidepressants for depression.
    Geddes JR; Freemantle N; Mason J; Eccles MP; Boynton J
    Cochrane Database Syst Rev; 2007 Jul; 2006(3):CD001851. PubMed ID: 17636689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
    Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD011681. PubMed ID: 25931277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does randomized evidence support sertraline as first-line antidepressant for adults with acute major depression? A systematic review and meta-analysis.
    Cipriani A; Furukawa TA; Geddes JR; Malvini L; Signoretti A; McGuire H; Churchill R; Nakagawa A; Barbui C;
    J Clin Psychiatry; 2008 Nov; 69(11):1732-42. PubMed ID: 19026250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antidepressants for people with epilepsy and depression.
    Maguire MJ; Marson AG; Nevitt SJ
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. General practitioners' perceptions of the tolerability of antidepressant drugs: a comparison of selective serotonin reuptake inhibitors and tricyclic antidepressants.
    Martin RM; Hilton SR; Kerry SM; Richards NM
    BMJ; 1997 Mar; 314(7081):646-51. PubMed ID: 9066479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The association between suicidality and treatment with selective serotonin reuptake inhibitors in older people with major depression: a systematic review.
    KoKoAung E; Cavenett S; McArthur A; Aromataris E
    JBI Database System Rev Implement Rep; 2015 Apr; 13(3):174-205. PubMed ID: 26447056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparison of the efficacy of traditional antidepressive agents and the new generation of antidepressives in the treatment of depressive disorders].
    Cvjetković-Bosnjak M; Knezević A; Soldatović-Stajić B
    Med Pregl; 1999; 52(3-5):108-11. PubMed ID: 10518394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.
    Anderson IM
    J Affect Disord; 2000 Apr; 58(1):19-36. PubMed ID: 10760555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: systematic review and meta-analysis.
    Watanabe N; Omori IM; Nakagawa A; Cipriani A; Barbui C; McGuire H; Churchill R; Furukawa TA;
    J Clin Psychiatry; 2008 Sep; 69(9):1404-15. PubMed ID: 19193341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tricyclic antidepressants and headaches: systematic review and meta-analysis.
    Jackson JL; Shimeall W; Sessums L; Dezee KJ; Becher D; Diemer M; Berbano E; O'Malley PG
    BMJ; 2010 Oct; 341():c5222. PubMed ID: 20961988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 73.